Casey, the newborn daughter of one of the authors of this paper, received a
positive result on an experimental medical screening test, indicating that
she may lack an enzyme required to digest certain fats. The interpretation
of this test result was complicated by uncertainty about the false-positiv
e rate for the test-this was the first positive reading-and the prevalence
of the medical condition. We used a simple Bayesian model to help assess th
e probability that Casey actually had the enzyme deficiency and to help bet
ter understand the role and value of this screening test. The model we used
and, more generally, our style of analysis could also be used with other n
ew diagnostic tests, such as tests used in manufacturing and environmental
contexts as well as other medical situations.